Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis
Refractory secondary progressive multiple sclerosis (SPMS) remains an area of unmet need, particularly once disability continues to accumulate despite multiple disease-modifying therapies. Two SPMS patients are reported with C-CAR168 treatment, a bispe…